HEM Pharma Inc.
Develops microbiome-based healthcare solutions, products, and CDMO services.
376270 | KO
Overview
Corporate Details
- ISIN(s):
- KR7376270005
- LEI:
- Country:
- South Korea
- Address:
- 경기도 수원시 영통구 창룡대로256번길 50 711호, 수원시
- Website:
- https://hempharma.bio/
- Sector:
- Manufacturing
Description
HEM Pharma Inc. is a biotechnology company specializing in microbiome-based healthcare solutions. The company researches and develops Live Biotherapeutic Products (LBPs), health functional foods, and other bio-products derived from human-effective microbes. A core component of its R&D is the proprietary Pharmaceutical Meta-Analysis System (PMAS), a technology platform that simulates the human gut microbiome to screen for and analyze beneficial microorganisms. In addition to its product pipeline, HEM Pharma provides personalized healthcare services based on microbiome analysis and offers Contract Development and Manufacturing Organization (CDMO) services for next-generation biological materials.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-03-21 00:00 |
사업보고서 (2024.12)
|
Korean | 1.2 MB | ||
| 2025-03-21 00:00 |
기업설명회(IR)개최
|
Korean | 6.8 KB | ||
| 2025-03-14 00:00 |
주주총회소집공고
|
Korean | 141.1 KB | ||
| 2025-03-13 00:00 |
[기재정정]매출액또는손익구조30%(대규모법인은15%)이상변동
|
Korean | 19.9 KB | ||
| 2025-03-13 00:00 |
주주총회소집결의
|
Korean | 19.0 KB | ||
| 2025-03-11 00:00 |
기업설명회(IR)개최
|
Korean | 6.7 KB | ||
| 2025-02-14 00:00 |
매출액또는손익구조30%(대규모법인은15%)이상변동
|
Korean | 11.4 KB | ||
| 2025-01-02 00:00 |
기업설명회(IR)개최
|
Korean | 6.7 KB | ||
| 2024-12-13 00:00 |
주주명부폐쇄기간또는기준일설정
|
Korean | 4.1 KB | ||
| 2024-11-28 00:00 |
신규시설투자등
|
Korean | 8.2 KB | ||
| 2024-11-14 00:00 |
분기보고서 (2024.09)
|
Korean | 991.3 KB | ||
| 2024-11-12 00:00 |
주식등의대량보유상황보고서(약식)
|
Korean | 68.6 KB | ||
| 2024-11-12 00:00 |
주식등의대량보유상황보고서(약식)
|
Korean | 88.2 KB | ||
| 2024-11-11 00:00 |
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 21.5 KB | ||
| 2024-11-11 00:00 |
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 21.6 KB |
Automate Your Workflow. Get a real-time feed of all HEM Pharma Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for HEM Pharma Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for HEM Pharma Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
